Reed Jobs’s cancer-focused venture firm Yosemite closed its second fund at $350 million, backed by Amgen, AbbVie, MIT, Memorial Sloan Kettering, and John Doerr.
Need help?
Contact usReed Jobs’s cancer-focused venture firm Yosemite closed its second fund at $350 million, backed by Amgen, AbbVie, MIT, Memorial Sloan Kettering, and John Doerr.